Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1267 |
---|---|
Product Name | Anti-Human TYRP1 Recombinant Antibody |
Molecular Name | Flanvotumab |
Alias | Anti-TYRP1 Recombinant Antibody, Research Grade Flanvotumab |
CAS Number | 1188277-05-5 |
Target | TYRP1[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Buffer | PBS, pH7.5 |
Background | Flanvotumab, also known as IMC-20D7S, is a human monoclonal antibody designed for the treatment of melanoma. It targets TYRP1. Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |